OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 20K CORT derivative securities | OQRO

Home
Insider trades
Corcept Therapeutics
Officer exercised or converted 20K CORT derivative securities

Insider trades

Insider trade

Officer exercised or converted 20K CORT derivative securities

Traded Jul 7, 2026 · Filed Jul 9, 2026

CORCorcept TherapeuticsCORT

20K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jul 7, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 9, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-26-298865

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Jul 9, 2026, 3:54 AM UTC

Added to OQRO

Oct 6, 2026, 7:14 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

CORCEPT THERAPEUTICS INC

Issuer CIK

1088856

Ticker

CORT

Reporting person

William Guyer

Relationship

Officer

Officer title

Chief Development Officer

Security

Stock Option (right to buy)

Table

Derivative (Table II)

Transaction date

Jul 7, 2026

Transaction code

Shares / units

20,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

130,000

Ownership form

Direct

Amendment

Footnotes from the filing

Fully exercisable.

Around the same time

William GuyerChief Development Officer

Filed 2mo ago

3,700Shares · @ $21.65

Traded Aug 4 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

William Guyer (Chief Development Officer) sold ~$419K of Corcept Therapeutics

Scheduled in advanceFiled 2mo ago

William GuyerChief Development Officer

Filed 2mo ago

3,700Derivative units

Traded Aug 4 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record